Defunct Company
Total Trials
10
As Lead Sponsor
6
As Collaborator
4
Total Enrollment
1,752
NCT01146782
Study of a Sleep Apnea System for the Treatment of Obstructive Sleep Apnea
Phase: N/A
Role: Lead Sponsor
Start: Jun 30, 2010
Completion: Mar 31, 2012
NCT01476917
The ATLAST Long-Term Study
Phase: Phase 2/3
Start: Nov 30, 2011
Completion: Oct 31, 2012
NCT01634074
Reiterative Development and Evaluation Study of OSA Therapy System
Start: Jul 31, 2012
Completion: Jul 31, 2014
NCT01683721
Post-Market Observational Study of the WINX Sleep Therapy for the Treatment of Obstructive Sleep Apnea (OSA)
Start: Sep 30, 2012
Completion: Feb 28, 2014
NCT02599259
Using Artificial Intelligence to Measure and Optimize Adherence in Patients on Anticoagulation Therapy.
Start: Mar 31, 2015
Completion: Apr 30, 2016
NCT02243670
Using Artificial Intelligence To Monitor Medication Adherence in Opioid Replacement Therapy
Start: Aug 31, 2016
Completion: Mar 31, 2017
NCT03127358
Smartphone Based aDOT Treatment With Fixed-Dose Elbasvir and Grazoprevir in PWIDs
Role: Collaborator
Start: Nov 14, 2017
Completion: Feb 6, 2019
NCT03387462
DOT Diary Optimization Pilot: A Pilot Study to Optimize the DOT Diary App to Measure PrEP Adherence
Phase: Phase 4
Start: Feb 28, 2018
Completion: Aug 30, 2018
NCT03771638
DOT Diary Mobile App for Pre-Exposure Prophylaxis Adherence in Young Men
Start: Feb 1, 2019
Completion: Apr 21, 2020
NCT05789875
Youth Ending the HIV Epidemic
Start: Jan 31, 2023
Completion: Sep 8, 2023